Haematology

Haematology covers everything from cancers of the blood to rare bleeding disorders, like haemophilia. Currently in Australia, there are more than 3,200 people diagnosed with haemophilia a, with varied degrees of severity.1 Blood cancers remain among the most prevalent and signicant diseases impacting Australian communities today; more than 19,400 people are diagnosed each year and more than 135,000 blood cancer survivors are living across Australia.2

Though diverse in nature, what is common across many of these diseases is the serious impact they can have on survival and quality of life.

Despite considerable progress over the years, many patients still have limited treatment options available to them. To tackle these challenges, we have embarked on journeys of collaboration with academic institutions, regulatory authorities and other companies in the hope of identifying trends or insights from the vast amounts of clinical data across blood diseases, which in turn could lead to future innovations.

Our commitment extends beyond developing innovative therapies, to playing a wider role in improving patient’s quality of life. We are exploring the best ways to deliver innovations to patients as quickly and effectively as possible, which includes evolving and improving how our clinical trials are designed and how our therapies are administered. We are also looking at new ways to measure treatment success through the use of alternative clinical endpoints.

We continue to invest in bringing innovative treatment options to people with diseases of the blood, as our teams strive to continually deliver transformational change for patients and the physicians who treat them.

References

1. Haemophilia Foundation Australia. Fast Facts [Internet; cited November 2024] Available from:

2. State of the nation: Blood cancers in Australia report 2023 [Internet; cited November 2024] Available from: